Patients
pharmaphorum podcast episode 91

Clinical trial diversity: An update

Editor-in-chief Jonah Comstock welcomes back returning guest Dr Jennifer Jones-McMeans, divisional vice president for global affairs for Abbott’s vascular business.

Sales & Marketing
pharmaphorum podcast episode 90

Changing personnel dynamics in the pharma world

An economic downturn always has effects that reverberate across an industry, and perhaps one of the most visible reverberations is in the realm of personnel - more layoffs and less hiring a

Patients
pharmaphorum podcast episode 91

Clinical trial diversity: An update

Editor-in-chief Jonah Comstock welcomes back returning guest Dr Jennifer Jones-McMeans, divisional vice president for global affairs for Abbott’s vascular business.

Sales & Marketing
pharmaphorum podcast episode 90

Changing personnel dynamics in the pharma world

An economic downturn always has effects that reverberate across an industry, and perhaps one of the most visible reverberations is in the realm of personnel - more layoffs and less hiring a

Sales & Marketing

Sales & Marketing
pharmaphorum podcast episode 90

Changing personnel dynamics in the pharma world

An economic downturn always has effects that reverberate across an industry, and perhaps one of the most visible reverberations is in the realm of personnel - more layoffs and less hiring a

Digital

Digital
pharmaphorum podcast episode 87

AI in drug development: A reality check

In this episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock catches up with Adityo Prakash, CEO of Verseon, to shed some light on what the potential of AI in drug discovery

Market Access

Newsletters and Deep Dive
digital magazine

Oncology

Patients

Patients
pharmaphorum podcast episode 91

Clinical trial diversity: An update

Editor-in-chief Jonah Comstock welcomes back returning guest Dr Jennifer Jones-McMeans, divisional vice president for global affairs for Abbott’s vascular business.

Patients
pharmaphorum podcast episode 89a

Retaining the human quality of healthcare in DTx

As DTx Europe came to a close at the British Medical Association in London, pharmaphorum web editor Nicole Raleigh spoke with Digital Medicine Society (DiMe) program lead, Alex Despotovic,

R&D